Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D, White JB, Chou JF, Chen PJ, Kim TH, Khalil DN, El Dika IH, Columna K, Yaqubie A, Light JS, Shia J, Yarmohammadi H, Erinjeri JP, Wei AC, Jarnagin W, Do RKG, Solit DB, Capanu M, Shah RH, Berger MF, Abou-Alfa GK, Harding JJ. Cowzer D, et al. JCO Precis Oncol. 2023 Sep;7:e2300272. doi: 10.1200/PO.23.00272. JCO Precis Oncol. 2023. PMID: 37769223
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
Soares KC, Jolissaint JS, McIntyre SM, Seier KP, Gönen M, Sigel C, Nasar N, Cercek A, Harding JJ, Kemeny NE, Connell LC, Koerkamp BG, Balachandran VP, D'Angelica MI, Drebin JA, Kingham TP, Wei AC, Jarnagin WR. Soares KC, et al. Cancer Med. 2023 Jun;12(11):12272-12284. doi: 10.1002/cam4.5925. Epub 2023 Apr 16. Cancer Med. 2023. PMID: 37062071 Free PMC article.
Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care.
Chakraborty S, Ecker BL, Seier K, Aveson VG, Balachandran VP, Drebin JA, D'Angelica MI, Kingham TP, Sigel CS, Soares KC, Vakiani E, Wei AC, Chandwani R, Gonen M, Shen R, Jarnagin WR. Chakraborty S, et al. Clin Cancer Res. 2021 Nov 1;27(21):5891-5899. doi: 10.1158/1078-0432.CCR-21-1906. Epub 2021 Aug 25. Clin Cancer Res. 2021. PMID: 34433650 Free PMC article.
Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall Survival.
Velayati S, Elsakka A, Zhao K, Erinjeri JP, Marinelli B, Soliman M, Chevallier O, Ziv E, Brody LA, Sofocleous CT, Solomon SB, Harding JJ, Abou-Alfa GK, D'Angelica MI, Wei AC, Kingham PT, Jarnagin WR, Yarmohammadi H. Velayati S, et al. Curr Oncol. 2023 Oct 18;30(10):9181-9191. doi: 10.3390/curroncol30100663. Curr Oncol. 2023. PMID: 37887563 Free PMC article.
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection.
Jolissaint JS, Soares KC, Seier KP, Kundra R, Gönen M, Shin PJ, Boerner T, Sigel C, Madupuri R, Vakiani E, Cercek A, Harding JJ, Kemeny NE, Connell LC, Balachandran VP, D'Angelica MI, Drebin JA, Kingham TP, Wei AC, Jarnagin WR. Jolissaint JS, et al. Clin Cancer Res. 2021 Jul 15;27(14):4101-4108. doi: 10.1158/1078-0432.CCR-21-0412. Epub 2021 May 7. Clin Cancer Res. 2021. PMID: 33963001 Free PMC article.
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma.
McIntyre SM, Preston WA, Walch H, Sharib J, Kundra R, Sigel C, Lidsky ME, Allen PJ, Morse MA, Chen W, Cercek A, Harding JJ, Abou-Alfa GK, O'Reilly EM, Park W, Balachandran VP, Drebin J, Soares KC, Wei A, Kingham TP, D'Angelica MI, Iacobuzio-Donahue C, Jarnagin WR. McIntyre SM, et al. JCO Precis Oncol. 2024 Feb;8:e2300534. doi: 10.1200/PO.23.00534. JCO Precis Oncol. 2024. PMID: 38394469